About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01383304

Aspirin Response in High Risk Patients With Coronary Artery Disease

Previous studies indicate that patients with cardiovascular disease have a variable response to aspirin. Despite treatment with aspirin a large number of patients suffer a myocardial infarction. This ...

Lead sponsor: University of Aarhus•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Aarhus

Collaborators

Aarhus University Hospital Skejby
Danish Heart Foundation

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Coronary artery disease verified by coronary angiogram
•Treatment with aspirin 75 mg/d for at least the previous 7 days
•Previous myocardial infarction more than one year ago (groups with previous myocardial infarction)
•Type 2 diabetes mellitus treated with oral antidiabetics and/or insulin (groups with type 2 diabetes mellitus)
•Renal insufficiency; glomerular filtration rate \<60 ml/min at the time of blood sampling (groups with renal insufficiency)

Exclusion Criteria

•Treatment with NSAIDs, clopidogrel, ticlopidine, dipyridamole, warfarin or any other drugs known to affect platelet function
•Ischemic vascular event within the previous 12 months
•Revascularization (angioplasty or coronary by-pass graft surgery) within the previous 12 months
•Platelet count \<120 x 10\^9/L or \>450 x 10\^9/L
•For patients without diabetes: fast glucose \>7 mmol/L
•Unable to give informed consent

Related studies

RECRUITINGPhase 1

A Trial Evaluating AMG 127 in Healthy Participants and Participants With Type 2 Diabetes Mellitus

NCT07590193 · Diabetes Mellitus, Type 2

Effect of Mobile-Based Home Cardiac Rehabilitation on Coronary Plaque

NCT07660419 · Coronary Artery Disease (CAD), Coronary Stenosis

Michigan Men's Diabetes Project III(MenDIII): Mind and Motion

NCT06574035 · Diabetes Mellitus, Type 2, Depressive Symptoms, and more

Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

NCT07011147 · Type 1 Diabetes (T1D), Type 2 Diabetes, and more

Arrhythmia Detection After MI

NCT05073419 · Acute Myocardial Infarction

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 12, 2016Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment906

Start dateNov 2007

Last updatedMay 12, 2016

Condition

Coronary Artery Disease Myocardial Infarction Diabetes Mellitus Renal Insufficiency, Chronic

Locations shown

Department of Clinical Biochemistry, Aarhus University Hospital, Skejby

Aarhus N

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 12, 2016Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions